Augmedix, Inc.

NASDAQ:AUGX

2.345 (USD) • At close October 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -19.171-24.449-17.851-15.604-18.498-24.163
Depreciation & Amortization 1.0980.8560.6910.8670.9491.588
Deferred Income Tax -1.3220-2.0570.7440.0690
Stock Based Compensation 2.4712.1121.3870.6680.3970.253
Change In Working Capital -1.8230.874-1.998-1.021.234-0.12
Accounts Receivables -2.3980.786-4.431-0.402-0.126-0.661
Inventory 001.04-0.1490.450
Accounts Payables -0.9470.0881.015-0.3970.3740
Other Working Capital 1.522-0.8740.378-0.0720.5360.541
Other Non Cash Items 3.3063.8341.236-0.0541.2042.548
Operating Cash Flow -15.441-16.773-18.592-14.399-14.645-19.895
Investing Activities:
Investments In Property Plant And Equipment -3.105-1.408-0.611-0.647-0.823-0.342
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 000000
Investing Cash Flow -3.105-1.408-0.611-0.647-0.823-0.342
Financing Activities:
Debt Repayment 5-1.1252.0342.681.9460
Common Stock Issued 38.7350.034027.41715.2750
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities -0.365-0.112-4.207-3.6815.22222.15
Financing Cash Flow 43.37-1.23737.82726.41717.16822.15
Other Information:
Effect Of Forex Changes On Cash -0.47-0.181-0.01-0.001-0.010.001
Net Change In Cash 24.966-19.59918.61411.371.6891.914
Cash At End Of Period 46.34221.98841.58722.97311.6039.914